Epidemiological Study on Invasive Bacterial Diseases
1 other identifier
observational
5,000
1 country
38
Brief Summary
Streptococcus pneumoniae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae (hemophilus) are among the main bacteria responsible for invasive bacterial diseases (MBIs) that result in severe clinical pictures also characterized by a high frequency of serious complications. Surveillance of infections caused by these pathogens and their distribution by serotypes/serogroups is essential to guide public health interventions, assess epidemiologic trends, monitor any secondary cases, estimate the proportion of preventable cases, identify any vaccine failures, and evaluate the impact of vaccine strategies.The present study aims to study the epidemiology of invasive bacterial diseases, characterize the circulating strains also in order to plan treatment and prevention strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2021
Longer than P75 for all trials
38 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 9, 2021
CompletedFirst Submitted
Initial submission to the registry
February 28, 2024
CompletedFirst Posted
Study publicly available on registry
March 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 30, 2032
March 21, 2024
March 1, 2024
10.1 years
February 28, 2024
March 18, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Incidence rate of Infective Bacterial Diseases from Streptococcus pneumoniae (pneumococcus) during the study period in pediatric age.
Monitor the trend of Infective Bacterial Diseases cases Streptococcus pneumoniae (pneumococcus) in Italy, during pediatric age.
Through study completion, an average of 1 year
Incidence rate of of Infective Bacterial Diseases cases from Neisseria meningitidis during the study period in pediatric age.
Frequencies of Infective Bacterial Diseases cases from Neisseria meningitidis in Italy (meningococcus)
Through study completion, an average of 1 year
Incidence rate of Infective Bacterial Diseases cases from Haemophilus influenzae during the study period in pediatric age.
Frequencies of Infective Bacterial Diseases cases from Haemophilus influenzae (hemophilus) in Italy
Through study completion, an average of 1 year
Secondary Outcomes (3)
Frequency of circulating serogroups/serotypes in Italy for S.pneumoniae, N.meningitidis, H.influenzae.
Through study completion, an average of 1 year
Proportion of these invasive infections (S.pneumoniae, N.meningitidis, H.influenzae) that are preventable by vaccine in Italy
Through study completion, an average of 1 yeary
Vaccine failure rate for S.pneumoniae, N.meningitidis, and H.influenzae.
Through study completion, an average of 1 year
Study Arms (1)
pneumococcal, meningococcal, and hemophilus Invasive Bacterial Diseases
Pediatric and adult patients diagnosed with pneumococcal, meningococcal, and hemophilus Invasive Bacterial Diseases, as defined in the Italian Superior Institute of Health (ISS) protocol.
Interventions
Molecular diagnosis of Invasive bacterial diseases due to Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae
Eligibility Criteria
Pediatric and adult patients diagnosed with pneumococcal, meningococcal, and hemophilus Infective bacterial disease in Italy
You may qualify if:
- Pediatric and adult patients diagnosed with pneumococcal, meningococcal, and hemophilus MBI
You may not qualify if:
- Other type of bacterial infections.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (38)
Ospedale di Adria
Adria, Italy
Ospedali riuniti di Ancona
Ancona, Italy
Ospedale di Andria
Andria, Italy
Ospedale Giovanni XXIII
Bari, Italy
Policlinico S.Orsola-Malpighi IRCCS
Bologna, Italy
Fondazione poliambulanza Brescia
Brescia, Italy
Ospedale Giovanni XXIII
Brescia, Italy
Ospedale di Campobasso
Campobasso, Italy
Ospedale Camposampiero
Camposampiero, Italy
Ospedale di Esine asst Valcamonica
Esine, Italy
Ospedale di Feltre (AULSS 1 Dolomiti)
Feltre, Italy
Immunology Laboratory Meyer Children's Hospital IRCCS
Florence, Italy
Ospedale Morgagni
Forlì, Italy
AO Salvini di Garbagnate
Garbagnate, Italy
Azienda sanitaria universitaria Giuliano Isontina (ASU GI)
Gorizia, Italy
Ospedale di Macerata
Macerata, Italy
Ospedale di Magenta
Magenta, Italy
Azienda Ospedaliera Policlinico Universitario "G. Martino"
Messina, Italy
IRCCS San Raffaele
Milan, Italy
AORN Santobono
Napoli, Italy
AOU Federico II di Napoli
Napoli, Italy
Ospedale di Novara
Novara, Italy
Fondazione I.R.C.C.S. Policlinico San Matteo
Pavia, Italy
Ospedale spirito santo di Pescara
Pescara, Italy
Azienda sanitaria Friuli occidentale
Pordenone, Italy
Ospedale degli infermi
Rimini, Italy
Ospedale Pediatrico Bambin Gesù IRCCS
Roma, Italy
Ospedale Sandro Pertini
Roma, Italy
Ospedale San Leonardo di Salerno
Salerno, Italy
Ospedale di Saronno
Saronno, Italy
AOU Sassari
Sassari, Italy
Ospedale di Scorrano
Scorrano, Italy
ASP Trapani
Trapani, Italy
IRCCS Materno Infantile Burlo Garofolo
Trieste, Italy
Azienda sanitaria universitaria Friuli Centrale (ASU FC)
Udine, Italy
Azienda ospedaliera universitaria integrata Verona
Verona, Italy
Ospedale civile di Vibo Valentia
Vibo Valentia, Italy
Ospedale Maggiore Carlo Alberto Pizzardi
Bologna, Ì, Italy
Biospecimen
Blood samples for bacterial identification
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full professor
Study Record Dates
First Submitted
February 28, 2024
First Posted
March 21, 2024
Study Start
December 9, 2021
Primary Completion (Estimated)
December 30, 2031
Study Completion (Estimated)
March 30, 2032
Last Updated
March 21, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share